AMP Certificate Program: 2016 World Health Organization (WHO) Updates in Hematologic Malignancies

This content was created in 2018, but has been reviewed and approved by the Training & Education Committee as useful, accurate, and relevant. Please note that in the time since this material was posted, there may have been additional developments, advancements, and/or more current publications in this field.

AMP Education is constantly updating our educational offerings, and will remove or replace content that is no longer accurate. Please be sure to use the search function to find related or updated material available in our catalogue at The Training and Education Committee works with AMP Education Programs to bring you the most up-to-date and cutting-edge information on molecular pathology research, applications, and training.

This AMP certificate program contains 5 hours of lecture content, the associated pdf slides of the lectures, a key reference sheet, post-course exam, and an AMP Certificate of Completion. It does not include CME/CMLE or SAM.

Since the publication of the World Health Organization (WHO) Classification of Tumors of Hematopoietic and Lymphoid Tissues in 2008, there have been significant advances in our knowledge of the biology and genetics of hematopoietic malignancies resulting in improved diagnostic and prognostic criteria, disease classification and therapeutic strategies. The 2016 WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues incorporates these advances with revisions to current entities and addition of provisional entities. This AMP certificate program will cover the major changes made in the 2016 WHO revision. Participants will learn from experts in the field covering the following topics: B lymphoid neoplasms, Peripheral T cell lymphomas, Acute Leukemias, Myeloproliferative Neoplasms, Myelodysplastic syndromes and Myelodysplastic/myeloproliferative neoplasms. An update on the clinicopathologic features and classification of hematologic malignancies will be presented providing participants with skills and knowledge to accurately diagnose and subclassify hematologic malignances according to the revised 2016 WHO criteria. 

Target Audience: Practicing pathologists, oncologists, medical trainees and other healthcare professionals in the U.S. and abroad.

Duration: 5 hours
AMP Certificate Program Launched: May 31, 2018
AMP Certificate of Completion Credit available:
Last day to purchase course and claim AMP Certificate of Completion: December 31, 2021


  • B-Lymphoid Neoplasms (and how practice is changing) (Recorded:  February 2018)
  • Nodal Peripheral T-cell Lymphomas (Recorded :January 2018)
  • Acute Leukemias (Recorded: January 2018)
  • Myeloproliferative Neoplasms (Recorded: March 2018)
  • Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms (Recorded:  February 2018)


Eric D. Hsi, MD Stefano A. Pileri, MD Daniel A. Arber, MD Tracy I. George, MD

Robert Hasserjian, MD Jennifer Dunlap, MD Mark D, Ewalt, MD
This certificate program was planned and coordinated by the Content Directors
  • Jennifer Dunlap, MD, Oregon Health & Science University, Portland, OR
  • Mark D, Ewalt, MD, University of Colorado, Denver, CO

and supported by the Training & Education Committee

There are no CME/CMLE or SAMs credits available for this certificate program.

Note: Join the AMP Family for discounted access to the most current educational resources!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

About AMP Certificate Programs: AMP Certificate Programs are thematically bundled packages containing some repurposed and some newly recorded content and does not necessarily build on previous recordings. It is designed to help you develop knowledge and skills needed for success in molecular pathology and diagnostics. Each program is reviewed, vetted, and curated by expert content directors. All certificate programs include a post-course final exam and an AMP Certificate of Completion. Some certificate programs are also available for CME/CMLE or SAMs credit.